Drugdiscovery >> Clinical Trials >> News
7209
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate - drugdiscovery.com
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate - drugdiscovery.com


The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1/2 study.
Read More >>


Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial - October 8, 2013
Related Articles
5150
Views
GSK’s  malaria vaccine candidate shows promise in Phase 3 trial GSK’s malaria vaccine candidate shows promise in Phase 3 trial
According to the results of a large-scale Phase 3 trial, the vaccine candidate RTS,S, showed efficient at protecting young children and infants from clinical malaria up to 18 months after vaccination. Read More >>

Tags: GSK, malaria vaccine, malaria, RTS,S, clinical trial

5995
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A Cystic fibrosis drug candidate shows positive results in Phase 1A
Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program. Read More >>

Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys

8256
Views
Glioblastoma multiforme vaccine successful in Phase 2 Glioblastoma multiforme vaccine successful in Phase 2
Agenus’ Prophage Series G-100 (HSPPC-96), used in combination with the current standard of care in patients with newly diagnosed glioblastoma multiforme, showed significant improvement in progressio Read More >>

Tags: glioblastoma multiiforme, GBM, vaccine, clinical trial, Ageon, HSPPC-96,progression free survival

7145
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

7450
Views
Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS
Cytokinetics’ drug Tirasemtiv, a fast skeletal muscle troponin activator, shows safe and tolerable in two prior Phase 2 trials in patients with amyotrophic lateral sclerosis (ALS). The compound is Read More >>

Tags: Tirasemtiv, ALS, clinical trial, skeletal muscle troponin activator, amyotrophic lateral sclerosis, Cytokinetics

3249
Views
Auris medical's first patient entered in Phase III Study for tinnitus Auris medical's first patient entered in Phase III Study for tinnitus
Auris announced that the first patient has entered the clinical trial phase III in Europe. Read More >>

Tags: europe, PhasII, Auris, Tinnitus

6399
Views
Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial
The experimental vaccine consists of a disk-shaped, biodegradable sponge which contains growth factors and components of each patient's tumors aiming to recruit and reprogram a patient’s own immune Read More >>

Tags: melanoma, cancer, clinical trial, skin, implant, implantable, vaccine

5240
Views
Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial
According to the results of Phase 2 clnical trial, Humira induced a significant response rate, compared to placebo, in adult patients with moderate-to-severe hidradenitis suppurativa (HS). The drug Read More >>

Tags: Humira, AbbVie, hidradenitis suppurativa, clinical trial

7067
Views
 Melflufen enters Phase II study in the treatment of multiple myeloma patients Melflufen enters Phase II study in the treatment of multiple myeloma patients
Melflufen, also known as J1, will be used in combination with dexamethasone for late stage, relapsing or relapsing/refractory patients with multiple myeloma. The aim of this phase study is to determi Read More >>

Tags: melflufen, J1, multiple myeloma, late stage, clinical trial

3165
Views
Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer
Merck Serono’s Erbitux (cetuximab) plus FOLFIRI, compared to bevacizumab plus FOLFIRI, has shown a clinically relevant improvement (7.5 month increase in median overall survival) as first-line tr Read More >>

Tags: Erbitux, cetuximab, clinical trail, metastatic, colorectal cancer, Merck, cancer therapy

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013